BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND AKT2, PKBBETA, 208, ENSG00000105221, RAC-BETA, P31751, PRKBB
114 results:

  • 1. LTX-315 and adoptive cell therapy using tumor-infiltrating lymphocytes generate tumor specific T cells in patients with metastatic soft tissue sarcoma.
    Nielsen M; Monberg T; Sundvold V; Albieri B; Hovgaard D; Petersen MM; Krarup-Hansen A; Met Ö; Camilio K; Clancy T; Stratford R; Sveinbjornsson B; Rekdal Ø; Junker N; Svane IM
    Oncoimmunology; 2024; 13(1):2290900. PubMed ID: 38125722
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Clinical spectrum and clinicopathological correlation of pediatric orbital tumors: 20 years' experience from a tertiary eye care center.
    Vijay V; Alam MS; Subramanian N; Krishnakumar S; Biswas J; Mukherjee B
    Indian J Ophthalmol; 2024 Feb; 72(2):249-257. PubMed ID: 38099389
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Charcot neuroarthropathy in persons with diabetes: It's time for a paradigm shift in our thinking.
    Wukich DK; Frykberg RG; Kavarthapu V
    Diabetes Metab Res Rev; 2024 Mar; 40(3):e3754. PubMed ID: 38069459
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Kaposi's sarcoma-associated herpesvirus viral protein kinase augments cell survival.
    Wu XJ; Zhang Z; Wong JP; Rivera-Soto R; White MC; Rai AA; Damania B
    Cell Death Dis; 2023 Oct; 14(10):688. PubMed ID: 37852997
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. RANKL acts an unfavorable prognostic biomarker and potential target in advanced KRAS-mutated lung adenocarcinoma.
    Li HS; Liu CM; Wang Y
    Thorac Cancer; 2023 May; 14(15):1368-1382. PubMed ID: 37021520
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Risk of obstetric and perinatal complications in women presenting with breast cancer during pregnancy and the first year postpartum in Sweden 1973-2017: A population-based matched study.
    Lundberg FE; Gkekos L; Rodriguez-Wallberg KA; Fredriksson I; Johansson ALV
    Acta Obstet Gynecol Scand; 2024 Apr; 103(4):684-694. PubMed ID: 36959086
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Osteosarcoma and causes of death: A report of 1520 deceased patients from the Cooperative Osteosarcoma Study Group (COSS).
    Bielack SS; Blattmann C; Borkhardt A; Csóka M; Hassenpflug W; Kabíčková E; Kager L; Kessler T; Kratz C; Kühne T; Kevric M; Lehrnbecher T; Mayer-Steinacker R; Mettmann V; Metzler M; Reichardt P; Rossig C; Sorg B; von Luettichau I; Windhager R; Hecker-Nolting S
    Eur J Cancer; 2022 Nov; 176():50-57. PubMed ID: 36191386
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clinical Impact of External Beam Radiotherapy for Surgically Resected Primary Retroperitoneal Liposarcoma.
    Erstad DJ; Chiang YJ; Witt RG; Cope B; Nassif EF; Scally CP; Torres KE; Feig BW; Hunt KK; Bishop AJ; Guadagnolo BA; Roland CL; Keung EZ
    Ann Surg Oncol; 2023 Feb; 30(2):926-940. PubMed ID: 36115928
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Combined inhibition of BET bromodomain and mTORC1/2 provides therapeutic advantage for rhabdomyosarcoma by switching cell death mechanism.
    Srivastava RK; Guroji P; Jin L; Mukhtar MS; Athar M
    Mol Carcinog; 2022 Aug; 61(8):737-751. PubMed ID: 35472745
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Lorlatinib for advanced anaplastic lymphoma kinase-positive non-small cell lung cancer: Results of the IFCT-1803 LORLATU cohort.
    Baldacci S; Besse B; Avrillon V; Mennecier B; Mazieres J; Dubray-Longeras P; Cortot AB; Descourt R; Doubre H; Quantin X; Duruisseaux M; Monnet I; Moro-Sibilot D; Cadranel J; Clément-Duchêne C; Cousin S; Ricordel C; Merle P; Otto J; Schneider S; Langlais A; Morin F; Westeel V; Girard N
    Eur J Cancer; 2022 May; 166():51-59. PubMed ID: 35278825
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Research Progress of Exosome-Loaded miRNA in Osteosarcoma.
    Yao P; Lu Y; Cai Z; Yu T; Kang Y; Zhang Y; Wang X
    Cancer Control; 2022; 29():10732748221076683. PubMed ID: 35179996
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [HIV First Diagnoses in Germany in 2014 - A Regional Analysis].
    Thomas Schleenvoigt B; Ankert J; Stocker H; Stoehr A; Lehmann C; Schulz C; Wesselmann H; Bickel M; Haberl A; Degen O; Pletz MW; Seybold U; Stephan C; ;
    Gesundheitswesen; 2022 Nov; 84(11):e45-e52. PubMed ID: 35176792
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Impact of treatment refusal and abandonment on survival outcomes in pediatric osteosarcoma in Southeast Asia: A multicenter study.
    Monsereenusorn C; Alcasabas AP; Loh AHP; Soh SY; Leung KWP; Kimpo M; Dhamne C; Blair S; Lam C; Photia A; Rujkijyanont P; Traivaree C; Pairojboriboon S; Rodriguez-Galindo C;
    Pediatr Blood Cancer; 2022 Apr; 69(4):e29556. PubMed ID: 35038209
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. An Extensive Presentation of Cutaneous Angiosarcoma.
    Ahlers CG; Zwerner JP; Parker ER
    J Drugs Dermatol; 2021 Aug; 20(8):895-897. PubMed ID: 34397202
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. TP53 mutations increase radioresistance in rhabdomyosarcoma and Ewing sarcoma.
    Casey DL; Pitter KL; Wexler LH; Slotkin EK; Gupta GP; Wolden SL
    Br J Cancer; 2021 Aug; 125(4):576-581. PubMed ID: 34017087
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Profiling of three H3F3A-mutated and denosumab-treated giant cell tumors of bone points to diverging pathways during progression and malignant transformation.
    Hasenfratz M; Mellert K; Marienfeld R; von Baer A; Schultheiss M; Roitman PD; Aponte-Tinao LA; Lehner B; Möller P; Mechtersheimer G; Barth TFE
    Sci Rep; 2021 Mar; 11(1):5709. PubMed ID: 33707617
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Anti-programmed cell death-1 therapy in octogenarian and nonagenarian advanced/metastatic melanoma patients.
    Cybulska-Stopa B; Ziętek M; Kamińska-Winciorek G; Czarnecka AM; Piejko K; Galus Ł; Ziółkowska B; Kieszko S; Kempa-Kamińska N; Calik J; Zemełka T; Kubiatowski T; Suwiński R; Mackiewicz J; Rutkowski P
    Melanoma Res; 2021 Feb; 31(1):49-57. PubMed ID: 33165240
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Does iatrogenic tumor rupture during surgery have prognostic implications for the outcome of uterine sarcomas?
    Benito V; Lubrano A; León L; Molano F; Pinar B
    Int J Gynecol Cancer; 2020 Nov; 30(11):1726-1732. PubMed ID: 32948637
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A phase I trial of talazoparib and irinotecan with and without temozolomide in children and young adults with recurrent or refractory solid malignancies.
    Federico SM; Pappo AS; Sahr N; Sykes A; Campagne O; Stewart CF; Clay MR; Bahrami A; McCarville MB; Kaste SC; Santana VM; Helmig S; Gartrell J; Shelat A; Brennan RC; Hawkins D; Godwin K; Bishop MW; Furman WL; Stewart E
    Eur J Cancer; 2020 Sep; 137():204-213. PubMed ID: 32795876
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Evaluation of cell blocks from effusion specimens in Gynecologic Oncopathology: An experience of 220 cases, diagnosed at a Tertiary Cancer Referral Center.
    Rekhi B; Karmarkar S; Gupta C; Deodhar KK; Menon S; Pathuthara S; Maheshwari A; Shylasree TS; Gupta S
    Indian J Pathol Microbiol; 2020; 63(3):427-434. PubMed ID: 32769333
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.